China Universal Asset Management Co., Ltd. Maxcyte, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $893 Million
- Q3 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Maxcyte, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 20,212 shares of MXCT stock, worth $86,911. This represents 0.01% of its overall portfolio holdings.
Number of Shares
20,212
Previous 12,282
64.57%
Holding current value
$86,911
Previous $48,000
62.5%
% of portfolio
0.01%
Previous 0.01%
Shares
14 transactions
Others Institutions Holding MXCT
# of Institutions
124Shares Held
65.6MCall Options Held
1KPut Options Held
2K-
Cadian Capital Management, LP New York, NY8.19MShares$35.2 Million1.63% of portfolio
-
Black Rock Inc. New York, NY8.14MShares$35 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.78MShares$24.8 Million0.0% of portfolio
-
Vitruvian Partners LLP5.04MShares$21.7 Million7.62% of portfolio
-
Morgan Stanley New York, NY4.82MShares$20.7 Million0.0% of portfolio
About MAXCYTE, INC.
- Ticker MXCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 101,724,000
- Market Cap $437M
- Description
- MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...